LONDON: Serum Institute of India CEO Adar Poonawalla played on Wednesday Covishield was not approved for the EU Green Pass, said, “This is not a controversy at all.
It was destroyed outside the proportion.” “Ema is true in asking us to apply, which we have through Astrazeneca a month ago, and the process must take time.
In a month we believe EMA will approve the covishield.
There is no reason for it based on AstraZeneca data and our products are identical to astrazeneca more or less , “he said.
Green Pass, who will be asked to travel in the EU from July 1, currently does not recognize covishield.
Speaking at the Indian global forum, Poonawalla said “What makes it stay at night” is a lack of preparedness for future pandemic.
He calls for harmonization between regulatory countries vaccine producers must fulfill and harmonize the vaccine certificate.
“Until everything becomes regular, we will struggle to meet the results needed,” he said.
He said rule out intellectual property rights would not resolve the lack of vaccines immediately because it was not only about patents but also shared the technology process.
Previously in the year SII was forced to stop his exports through Covax to low-income countries to focus on Indian vaccination.
This is a “very stressful time” he said, explaining that the advanced money must be returned.
“India will return to support Covax within two to three months and start exporting vaccines.
At the end of the year there will be so many doses that come out of India,” he said.
“At the end of December, most Indian residents must be vaccinated,” he said.
SII has increased from 50 million doses of covid vaccine per month in January to 90 million in June.
But he warned pandemics may not end up to four years.
Adar Poonawalla said the problem of EU Green Pass Covishield has been ‘exploded from proportion’
